Testicular Cancer: Self Exam and Warning Signs

Understanding What’s Actually Happening in Testicular Cancer

Think of your testicles like specialized factories producing two critical products: testosterone (the hormone) and sperm (the reproductive cells). Inside each testicle, germ cells—the cells that eventually become sperm—undergo controlled division. When something goes wrong with that control mechanism, one of these cells divides wildly and uncontrollably, forming a tumor. Unlike many cancers, testicular tumors grow relatively quickly. A man might feel nothing one month and have a marble-sized lump three months later. The concerning part isn’t just the local tumor itself; it’s whether cancer cells have slipped into the lymph nodes in the abdomen or spread to the lungs and brain. That’s why size, type of cancer, and early detection change everything about your prognosis.

Causes and Risk Factors: What Actually Matters

Here’s the honest truth: most men who get testicular cancer have no obvious risk factor. The disease doesn’t care about your lifestyle choices, gym routine, or diet. But certain conditions do elevate your risk significantly.

Undescended testicle (cryptorchidism) remains the strongest established risk factor. During fetal development, testicles normally descend from the abdomen into the scrotum. When this doesn’t happen completely—whether one or both testicles stay high—the risk of cancer increases approximately 40 times. Paradoxically, even surgical correction after age 10 doesn’t fully eliminate this elevated risk, suggesting the developmental abnormality itself carries inherent danger.

Family history matters more than most men realize. Men whose father or brother had testicular cancer carry roughly a 10-fold increased risk. This isn’t about some doom-and-gloom inevitability; it means screening becomes even more critical.

Prior testicular cancer in the opposite testicle occurs in 2-5% of survivors, making lifelong surveillance standard.

Here’s what most articles skip: intratesticular microlithiasis—tiny calcium deposits visible on ultrasound—appears in 1% of the general population but in 5-11% of testicular cancer patients. If your ultrasound mentions this incidental finding, it warrants careful follow-up imaging but doesn’t automatically mean you have cancer. It means your baseline risk sits higher than average.

Age matters too. While testicular cancer can strike at any age, the peak incidence happens between 20 and 39. A 22-year-old college student finding a lump should take it seriously, but so should a 45-year-old—testicular cancer isn’t exclusively a young man’s disease.

Signs and Symptoms: What Actually Feels Wrong

The hallmark sign is a painless lump or hardness in the testicle. But here’s what catches most guys off-guard: it rarely starts with dramatic symptoms. Men often describe noticing their testicle feels slightly heavier, or they catch themselves touching it more often because something feels different. The lump might be pea-sized initially—you’d only find it if you were deliberately examining yourself.

Pain does occur in about 10% of cases, but it’s usually a dull ache rather than sharp agony. Swelling in the scrotum without a discrete lump can signal fluid accumulation (hydrocele) rather than cancer, but it deserves evaluation.

Here’s the overlooked early sign many articles miss: changes in breast tissue. About 5% of testicular cancer patients develop gynecomastia—breast swelling or tenderness—from hormones produced by the tumor itself. A man notices his chest feels tender or puffy and never connects it to his testicles. This happens because certain germ cell tumors secrete human chorionic gonadotropin (hCG) or alpha-fetoprotein (AFP), hormones that can stimulate breast tissue growth.

Later signs include persistent low back pain (from enlarged abdominal lymph nodes compressing nerves), shortness of breath (from lung metastases), or headaches and dizziness (from brain involvement). But by then, the cancer has already spread.

Diagnosis: What Happens When You Find Something

First, you call your primary care doctor or urologist. They’ll ask when you noticed it and whether it hurts. Then they perform a physical exam—careful palpation of both testicles to characterize the lump’s size, firmness, and whether it’s attached to surrounding tissue.

The next step is ultrasound—a painless imaging test using sound waves. Ultrasound is remarkably good at distinguishing between benign conditions (like cysts, varicoceles, or hydroceles) and suspicious lesions. A suspicious mass appears as an area of low echogenicity (darker on the image) within the testicle. This single test dramatically narrows the differential diagnosis.

If ultrasound raises concern, your urologist orders serum tumor markers: AFP (alpha-fetoprotein), hCG (human chorionic gonadotropin), and LDH (lactate dehydrogenase). These proteins circulate in your bloodstream. Certain testicular cancers produce them. Normal levels don’t rule out cancer, but elevated levels confirm the diagnosis exists.

Here’s the hard part: confirmation requires removing the testicle surgically—radical inguinal orchiectomy. Doctors don’t biopsy the testicle itself because needle biopsy risks spreading cancer cells. Instead, they access the testicle through an incision in the groin, remove it completely, and have pathologists examine it under a microscope. The pathology report then tells you the exact type of cancer, stage, and what you’re dealing with.

Treatment Options: Current Standards That Actually Work

Treatment depends entirely on cancer type and stage. Here’s the framework:

For seminomas (the more common type at 40% of cases): Radiation therapy to abdominal lymph nodes historically dominated treatment. Now, chemotherapy with BEP regimen—bleomycin, etoposide, and cisplatin given intravenously over 5 days, repeated in cycles—offers equivalent survival without long-term radiation risks. Early-stage seminomas often receive just one or two chemotherapy cycles.

For nonseminomatous germ cell tumors: Chemotherapy is the backbone. The same BEP regimen works, but advanced disease may require three or four cycles instead of two. Some patients receive EP (etoposide-cisplatin) without bleomycin depending on risk stratification.

Surveillance protocol: Here’s what surprises many men—not everyone needs chemotherapy. Stage 1 patients (cancer confined to the testicle with no lymph node involvement) have a choice. Some pursue one course of adjuvant chemotherapy to eliminate micrometastatic disease that imaging can’t detect. Others choose observation with serial imaging and tumor markers every 2-4 weeks. Both approaches yield equivalent 5-year survival above 99%, but chemotherapy accepts short-term toxicity for peace of mind, while observation requires discipline and anxiety tolerance.

Advanced disease (stage 3): Chemotherapy becomes mandatory. Three to four BEP cycles followed by evaluation of residual masses. Larger residual masses sometimes require surgical removal (retroperitoneal lymph node dissection) afterward.

Survival outcomes have improved dramatically. According to JAMA Oncology studies, overall 5-year survival for testicular cancer now exceeds 95% in developed countries, reflecting both better chemotherapy and earlier detection.

Practical Daily Management: Concrete Steps

Master the self-exam technique. Perform it monthly after a warm shower when the scrotum is relaxed. Stand in front of a mirror. Gently roll each testicle between your thumbs and fingers, feeling for lumps, swelling, or hardness. What you’re feeling for isn’t pain or dramatic change—it’s a small area within the testicle that feels different, harder, or nodular compared to the surrounding tissue. Most testicles contain small, completely benign structures like the epididymis (a coiled tube along the back). Know your baseline so you notice actual changes.

If you find something, don’t panic but do act. Call your doctor the same day or next morning. Most scrotal lumps aren’t cancer—cysts, varicoceles, and hydroceles are common and benign—but only imaging rules them out.

Keep a log. Write down when you perform exams and what you feel. This gives your doctor a timeline and helps you distinguish between obsessive checking (which just makes you anxious) and legitimate monitoring.

Know your risk factors. If you have a family history, undescended testicle history, or prior testicular cancer, discuss baseline ultrasound screening with your urologist. Don’t wait for symptoms.

After treatment, follow your surveillance schedule religiously. This means physical exams, tumor marker blood tests, and imaging at specific intervals—usually monthly for the first year, then gradually extending. Recurrence happens, but it’s caught early when surveillance is tight.

Prevention: What the Evidence Shows

Here’s the uncomfortable reality: you can’t prevent testicular cancer the way you prevent heart disease by exercising or quitting smoking. The disease arises from developmental abnormalities and genetic accidents, not lifestyle factors.

What you can do: early detection through self-examination. This isn’t prevention in the traditional sense, but it’s prevention of advanced disease. Finding a lump at 2 millimeters versus 2 centimeters changes your treatment intensity and long-term quality of life dramatically.

For men with undescended testicles: surgical correction (orchiopexy) should happen before age 10 if possible. This doesn’t eliminate cancer risk entirely, but it may lower it compared to leaving the testicle in the abdomen. Correction after age 10 carries no protective benefit.

For men with prior testicular cancer: close follow-up of the remaining testicle through self-exam and periodic ultrasound catches contralateral cancer early, when cure rates remain above 95%.

<div class="h